The multiple impurities noted in ibuprofen synthesis are substantially more than those noted in the case of paracetamol synthesis, despite having similar reagents. Our observation further highlights the need for raw materials risk assessments in the context of individual reactions, and evaluation of what reaction products can result from known impurities in starting materials.